UK Expands Vaccine Rollout as Global Immunisation Drive Gears Up 

4 min read | January 18, 2021 10:29 PM AEDT | By Kunal Sawhney

Summary

  • The UK health administration has already immunised more than 3.8 million people across the country.
  • PM Boris Johnson has assured that the first four groups will receive the vaccine by the middle of February.
  • The healthcare authorities will be setting up 10 mass inoculation centres in England this week.

 

The UK healthcare administration is all set to widen the ongoing vaccination programme in the next few weeks as the global Covid-19 inoculation drive attains pace following the approval of coronavirus shots developed by various vaccine makers. After vaccinating nearly 45 per cent of the people in the age group of 80 years or more, the authorities are now aiming to immunise millions of individuals in the age bracket of 70-80 years.  

 

UK expands vaccine rollout 

 

The decision of including people above the age of 70 years in the extant vaccination programme has been duly taken after the government prescribed a ban on quarantine-free travel into the UK. The UK healthcare administration is now focussing on vaccinating the vulnerable patients, the remaining frontline workers, and the people over the age of 70s.  

 

Collectively, the UK health administration has already immunised more than 3.8 million people across the country including the clinically vulnerable patients, frontline workers, primarily NHS staff, people deployed in high infection areas and social care individuals, and people above the age of 80 years.  

(Image source: ©Kalkine Group 2020)

 

Now, the first dose of the coronavirus vaccine will be administered to the next two focus groups in the upcoming weeks starting from Monday, 18 January. The authorities have been mandated by the government to vaccinate subsequent groups if the supply is adequate.  PM Boris Johnson has recently assured that the first four priority groups will get the first dose of the vaccine by the middle of February.  

 

As per the government, approximately 45 per cent in the age bracket of 80 years or more in England have received the first vaccine dose from the NHS. Notably, more than a million individuals falling in the corresponding age group have been invited to book their jabs at one of the vaccination centres.  

 

Foreign Secretary Dominic Raab on Sunday said that the government intends to inoculate all the adults with the first dose of the Covid-19 vaccine by September.  

 

Health Secretary Matt Hancock has separately said that the government is determined to offer the first dose of vaccine to all the clinically endangered patients, frontline workers and the next focus group. 

 

In this regard, the healthcare authorities will be setting up 10 mass inoculation centres in England in this week. According to the government, all the eligible people are being contacted either by a text message or a letter for fixing the appointment for the vaccination.  

 

In order to proceed with a large-scale vaccination target in the upcoming weeks, the NHS has configured various vaccination sites at GP surgeries, hospitals, and pharmacies across the widespread geography of the country alongside delivering the doses to the care home centres.  

 

Also Read:  AstraZeneca (LON:AZN) vaccine rollout gets extended to general practitioners

 

 

Brazil approves AstraZeneca vaccine 

 

Meanwhile, Brazilian Health Regulatory Agency Anvisa has approved the coronavirus vaccine, jointly developed by Cambridge-based pharmaceutical giant AstraZeneca Plc (LON: AZN) and the University of Oxford.  

 

Alongside the AstraZeneca’s Covid shot, the regulator has also given the go-ahead to the coronavirus vaccine prepared by the Beijing-based drug developer Sinovac Biotech.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.